160 related articles for article (PubMed ID: 15949532)
21. Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.
Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert AD; D'Antonio A; Losito S; Normanno N; Salomon DS
J Pathol; 2007 Jan; 211(1):36-44. PubMed ID: 17072826
[TBL] [Abstract][Full Text] [Related]
22. Modulation of TGF-beta signaling by EGF-CFC proteins.
Wechselberger C; Bianco C; Strizzi L; Ebert AD; Kenney N; Sun Y; Salomon DS
Exp Cell Res; 2005 Nov; 310(2):249-55. PubMed ID: 16137677
[TBL] [Abstract][Full Text] [Related]
23. Reduction of Cripto-1 expression by a hammerhead-shaped RNA molecule results from inhibition of translation rather than mRNA cleavage.
Kintner RL; Hosick HL
Biochem Biophys Res Commun; 1998 Apr; 245(3):774-9. PubMed ID: 9588190
[TBL] [Abstract][Full Text] [Related]
24. The Vg1-related protein Gdf3 acts in a Nodal signaling pathway in the pre-gastrulation mouse embryo.
Chen C; Ware SM; Sato A; Houston-Hawkins DE; Habas R; Matzuk MM; Shen MM; Brown CW
Development; 2006 Jan; 133(2):319-29. PubMed ID: 16368929
[TBL] [Abstract][Full Text] [Related]
25. Cripto-1-induced increase in vimentin expression is associated with enhanced migration of human Caski cervical carcinoma cells.
Ebert AD; Wechselberger C; Nees M; Clair T; Schaller G; Martinez-Lacaci I; Wallace-Jones B; Bianco C; Weitzel HK; Salomon DS
Exp Cell Res; 2000 May; 257(1):223-9. PubMed ID: 10854071
[TBL] [Abstract][Full Text] [Related]
26. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression.
Corsino P; Davis B; Law M; Chytil A; Forrester E; Nørgaard P; Teoh N; Law B
Cancer Res; 2007 Apr; 67(7):3135-44. PubMed ID: 17409420
[TBL] [Abstract][Full Text] [Related]
27. XCR2, one of three Xenopus EGF-CFC genes, has a distinct role in the regulation of left-right patterning.
Onuma Y; Yeo CY; Whitman M
Development; 2006 Jan; 133(2):237-50. PubMed ID: 16339189
[TBL] [Abstract][Full Text] [Related]
28. Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line.
Ciardiello F; Dono R; Kim N; Persico MG; Salomon DS
Cancer Res; 1991 Feb; 51(3):1051-4. PubMed ID: 1846316
[TBL] [Abstract][Full Text] [Related]
29. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
[TBL] [Abstract][Full Text] [Related]
30. Cripto-1: an embryonic gene that promotes tumorigenesis.
de Castro NP; Rangel MC; Nagaoka T; Salomon DS; Bianco C
Future Oncol; 2010 Jul; 6(7):1127-42. PubMed ID: 20624125
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
32. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.
Rangel MC; Karasawa H; Castro NP; Nagaoka T; Salomon DS; Bianco C
Am J Pathol; 2012 Jun; 180(6):2188-200. PubMed ID: 22542493
[TBL] [Abstract][Full Text] [Related]
33. Structural insights into the interaction between the Cripto CFC domain and the ALK4 receptor.
Calvanese L; Saporito A; Oliva R; D' Auria G; Pedone C; Paolillo L; Ruvo M; Marasco D; Falcigno L
J Pept Sci; 2009 Mar; 15(3):175-83. PubMed ID: 19035567
[TBL] [Abstract][Full Text] [Related]
34. Cripto-1 ablation disrupts alveolar development in the mouse mammary gland through a progesterone receptor-mediated pathway.
Klauzinska M; McCurdy D; Rangel MC; Vaidyanath A; Castro NP; Shen MM; Gonzales M; Bertolette D; Bianco C; Callahan R; Salomon DS; Raafat A
Am J Pathol; 2015 Nov; 185(11):2907-22. PubMed ID: 26429739
[TBL] [Abstract][Full Text] [Related]
35. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.
Bianco C; Adkins HB; Wechselberger C; Seno M; Normanno N; De Luca A; Sun Y; Khan N; Kenney N; Ebert A; Williams KP; Sanicola M; Salomon DS
Mol Cell Biol; 2002 Apr; 22(8):2586-97. PubMed ID: 11909953
[TBL] [Abstract][Full Text] [Related]
36. Role of the EGF-CFC gene cripto in cell differentiation and embryo development.
Minchiotti G; Parisi S; Liguori GL; D'Andrea D; Persico MG
Gene; 2002 Apr; 287(1-2):33-7. PubMed ID: 11992720
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival.
Gong YP; Yarrow PM; Carmalt HL; Kwun SY; Kennedy CW; Lin BP; Xing PX; Gillett DJ
Eur J Surg Oncol; 2007 May; 33(4):438-43. PubMed ID: 17125961
[TBL] [Abstract][Full Text] [Related]
38. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
39. Expression of cripto in human gall bladder lesions.
Fujii K; Yasui W; Kuniyasu H; Itoh M; Hanada K; Kajiyama G; Tahara E
J Pathol; 1996 Oct; 180(2):166-8. PubMed ID: 8976875
[TBL] [Abstract][Full Text] [Related]
40. Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas.
Hong SP; Lee EK; Park JY; Jeon TJ; Bang S; Park S; Chung JB; Lee WJ; Kim H; Song SY
Oncol Rep; 2009 Jan; 21(1):19-24. PubMed ID: 19082438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
